Viral Hepatitis

On Thursday, June 11, HepVu convened a webinar to discuss the impact of COVID-19 on harm reduction services, issues encountered on the ground, and potential solutions.

In collaboration with the National Viral Hepatitis Roundtable (NVHR), the Hepatitis Education Project (HEP), NASTAD, Hep B United, Hepatitis B Foundation, and National Association of County Health Officials (NACCHO), HepVu created a factsheet outlining the impact of the COVID-19 pandemic on viral hepatitis and the experiences of clinical providers, community-based organizations, and health departments during COVID-19.

The plan highlights goal-oriented objectives and strategies aimed at ultimately eliminating viral hepatitis as a public health threat in the U.S.

This technical package provides a broad framework for new and existing SSPs to ensure needs-based service delivery, reduce harms related to injection drug use, and link participants to services that support their health and wellness.

This fact sheet can help you understand and answer questions about what your blood tests mean and if you are infected, protected or at risk for hepatitis B.

This fact sheet provides prevention information on Hepatitis A.  

This document presents CDC's Division of Viral Hepatitis (DVH) 2025 goals and strategies to reduce new viral hepatitis infections, reduce viral hepatitis-related morbidity and mortality, and reduce viral hepatitis-related disparities.

This document outlines updated CDC guidance that includes recommendations for a testing algorithm and clinical management for HCP with potential occupational exposure to hepatitis C virus (HCV).

This annual surveillance report, summarizes information about reported cases of hepatitis A, hepatitis B, and hepatitis C and deaths with either of these hepatitis listed as a cause of death in CDC’s National Vital Statistics System (NVSS).